Tirzepatide is not FDA-approved specifically for PCOS, so using it for PCOS-related concerns would be considered off-label
10.1139/cjm-2013-0083 26 IbrahimD.MoustafaA.ShahinS
[2] Serious risks, though rare, include pancreatitis, gallbladder issues, and a potential for thyroid tumors
Strict adherence to professional guidelines helps minimize risks and ensures appropriate therapeutic oversight
This triple agonism reduces appetite, increases insulin secretion, and boosts energy expenditure by enhancing fat oxidation
Why Most GLP-1 Medicines Are Given by Injection GLP-1-based peptide medicines are injected because digestive enzymes rapidly break them down before oral absorption can occur, rendering conventional tablets or capsules ineffective